These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7489233)

  • 1. Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles.
    Cavallero E; Brites F; Delfly B; Nicolaïew N; Decossin C; De Geitere C; Fruchart JC; Wikinski R; Jacotot B; Castro G
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2130-5. PubMed ID: 7489233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients.
    Brites FD; Cavallero E; de Geitere C; Nicolaïew N; Jacotot B; Rosseneu M; Fruchart JC; Wikinski RL; Castro GR
    Clin Chim Acta; 1999 Jan; 279(1-2):1-14. PubMed ID: 10064113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I: A-II and LpA-IV particles from plasma.
    Duchateau P; Rader D; Duverger N; Theret N; De Geitere C; Brewer HB; Fruchart JC; Castro GR
    Biochim Biophys Acta; 1993 Aug; 1182(1):30-6. PubMed ID: 8347683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus.
    Ikewaki K; Mochizuki K; Iwasaki M; Nishide R; Mochizuki S; Tada N
    Metabolism; 2002 Oct; 51(10):1348-54. PubMed ID: 12370857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.
    Phillips C; Murugasu G; Owens D; Collins P; Johnson A; Tomkin GH
    Atherosclerosis; 2000 Feb; 148(2):283-91. PubMed ID: 10657563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid.
    Duverger N; Ghalim N; Ailhaud G; Steinmetz A; Fruchart JC; Castro G
    Arterioscler Thromb; 1993 Jan; 13(1):126-32. PubMed ID: 8422335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma.
    Duverger N; Rader D; Duchateau P; Fruchart JC; Castro G; Brewer HB
    Biochemistry; 1993 Nov; 32(46):12372-9. PubMed ID: 8241125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase.
    Ohta T; Nakamura R; Ikeda Y; Shinohara M; Miyazaki A; Horiuchi S; Matsuda I
    Biochim Biophys Acta; 1992 Nov; 1165(1):119-28. PubMed ID: 1420341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
    Leren TP; Bakken KS; Daum U; Ose L; Berg K; Assmann G; von Eckardstein A
    J Lipid Res; 1997 Jan; 38(1):121-31. PubMed ID: 9034206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.
    Adlouni A; El Messal M; Saïle R; Parra H; Fruchart J; Ghalim N
    Atherosclerosis; 2000 Oct; 152(2):433-40. PubMed ID: 10998472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels.
    Brites FD; Bonavita CD; De Geitere C; Cloës M; Delfly B; Yael MJ; Fruchart J; Wikinski RW; Castro GR
    Atherosclerosis; 2000 Sep; 152(1):181-92. PubMed ID: 10996354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
    Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
    Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels.
    Cavallero E; Dachet C; Neufcour D; Wirquin E; Mathe D; Jacotot B
    Metabolism; 1994 Mar; 43(3):270-8. PubMed ID: 8139473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.
    Borggreve SE; De Vries R; Dullaart RP
    Eur J Clin Invest; 2003 Dec; 33(12):1051-69. PubMed ID: 14636288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM.
    Bhatnagar D; Durrington PN; Kumar S; Mackness MI; Dean J; Boulton AJ
    Diabetes; 1995 Apr; 44(4):460-5. PubMed ID: 7698516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects.
    Eriksson JW; Burén J; Svensson M; Olivecrona T; Olivecrona G
    Atherosclerosis; 2003 Feb; 166(2):359-67. PubMed ID: 12535750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.
    O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Holmes D; Kottke BA
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):228-31. PubMed ID: 7749830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma.
    Huang Y; von Eckardstein A; Wu S; Assmann G
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1412-8. PubMed ID: 7670956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.